Form 4: Precision BioSciences Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Dario Scimeca, General Counsel and Secretary of Precision BioSciences, sold shares to cover tax withholding obligations related to vesting Restricted Stock Units (RSUs).
Summary
- On March 3, 2025, Dario Scimeca, General Counsel and Secretary of Precision BioSciences, vested 919 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of Precision BioSciences' Common Stock.
- On March 4, 2025, Scimeca sold 272 shares of Common Stock at a price of $4.91 per share.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2023.
- The shares were sold solely to cover tax withholding obligations associated with the vesting and settlement of the RSUs.
- Following the reported transactions, Scimeca beneficially owns 25,000 shares of Precision BioSciences' Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports stock transactions related to vesting RSUs and covering tax obligations. The use of a 10b5-1 plan suggests transparency and pre-planning.
Positives
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent approach to stock transactions.
- The executive retains a significant number of shares (25,000) after the sale, suggesting continued alignment with the company's success.
Future Outlook
There is no future outlook information provided in this document.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It's common for executives to sell shares to cover tax obligations related to vesting equity awards. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Stakeholder Impact
- The sale of shares by an executive could have a minor negative impact on shareholder sentiment, although the reason for the sale (tax obligations) is understandable.
- The use of a 10b5-1 plan provides transparency and may reassure stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/03/2022 | Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |
| 07/14/2023 | Rule 10b5-1 plan adopted. |
| 03/03/2025 | Vesting of 919 Restricted Stock Units (RSUs). |
| 03/04/2025 | Sale of 272 shares of Common Stock at $4.91 per share. |
| 03/05/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.